(Q53652839)
Statements
Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patients. French Ondansetron Study Group. (English)
M Clavel
J Bonneterre
H d'Allens
J M Paillarse
1 January 1995
31A
1
15-19